Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: A meta-analysis

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 17, Issue 1, 2012, Pages 44-56

  Bahekar, Amol ^a   Singh, Mukesh ^a   Singh, Sarabjeet ^a   Bhuriya, Rohit ^a   Ahmad, Khraisat ^a   Khosla, Sandeep ^a   Arora, Rohit ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

acute myocardial infarction; heart disease; myocardial

Indexed keywords

ACETYLSALICYLIC ACID; ALTEPLASE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIGITALIS; DIGOXIN; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOBUTAMINE; DOPAMINE; FUROSEMIDE; GLYCERYL TRINITRATE; HEPARIN; HYPERTENSIVE AGENT; LIDOCAINE; MORPHINE; NORADRENALIN; STREPTOKINASE; TICLOPIDINE;

ANGINA PECTORIS; ANGIOGRAPHY; AORTA BALLOON; ARTERY REOCCLUSION; ARTICLE; BLEEDING; CARDIOGENIC SHOCK; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; HEART ARREST; HEART DEATH; HEART INFARCTION; HEART LEFT VENTRICLE FAILURE; HEART REINFARCTION; HEART VENTRICLE ARRHYTHMIA; HUMAN; HYPOTENSION; ISCHEMIA; LUNG EDEMA; MANTEL HAENSZEL TEST; META ANALYSIS; MORTALITY; MULTICENTER STUDY (TOPIC); NON ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; PRIORITY JOURNAL; RANDOM ERROR; RANDOMIZED CONTROLLED TRIAL (TOPIC); RECURRENT DISEASE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; STROKE; SYSTEMATIC REVIEW; SYSTOLIC BLOOD PRESSURE; TRANSLUMINAL CORONARY ANGIOPLASTY;

HOSPITAL MORTALITY; HUMANS; INTRA-AORTIC BALLOON PUMPING; MYOCARDIAL INFARCTION; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RETROSPECTIVE STUDIES; RISK FACTORS; SHOCK, CARDIOGENIC; TREATMENT OUTCOME;

EID: 84863024172     PISSN: 10742484     EISSN: 19404034     Source Type: Journal    
DOI: 10.1177/1074248410395019     Document Type: Article

References (48)

1. Kantrowitz A, Tjonneland S, Freed PS, Phillips SJ, Butner AN, Sherman JL. Initial clinical experience with intraaortic balloon pumping in cardiogenic shock. JAMA. 1968 ; 203 (2). 113-118
2. Kantrowitz A.. Origins of intraaortic balloon pumping. Ann Thorac Surg. 1990 ; 50 (4). 672-674 (Pubitemid 20360840)
3. Scheidt S, Wilner G, Mueller H, et al. Intra-aortic balloon counterpulsation in cardiogenic shock. Report of a co-operative clinical trial. N Engl J Med. 1973 ; 288 (19). 979-984
4. O'Rourke MF, Sammel N, Chang VP.. Arterial counterpulsation in severe refractory heart failure complicating acute myocardial infarction. Br Heart J. 1979 ; 41 (3). 308-316 (Pubitemid 9142474)
5. Kahn JK, Rutherford BD, McConahay DR, Johnson WL, Giorgi LV, Hartzler GO.. Supported "high risk" coronary angioplasty using intraaortic balloon pump counterpulsation. J Am Coll Cardiol. 1990 ; 15 (5). 1151-1155 (Pubitemid 20104578)
6. Ferguson JJ, Cohen M, Freedman RJ, et al. The current practice of intra-aortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol. 2001 ; 38 (5). 1456-1462 (Pubitemid 33033026)
7. Patel JJ, Kopisyansky C, Boston B, Kuretu ML, McBride R, Cohen M.. Prospective evaluation of complications associated with percutaneous intraaortic balloon counterpulsation. Am J Cardiol. 1995 ; 76 (16). 1205-1207
8. Cohen M, Urban P, Christenson JT, et al. Intra-aortic balloon counterpulsation in US and non-US centres: results of the Benchmark Registry. Eur Heart J. 2003 ; 24 (19). 1763-1770 (Pubitemid 37236866)
9. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 1997 ; 29 (7). 1459-1467 (Pubitemid 27272437)
10. Mishra S, Chu WW, Torguson R, et al. Role of prophylactic intra-aortic balloon pump in high-risk patients undergoing percutaneous coronary intervention. Am J Cardiol. 2006 ; 98 (5). 608-612 (Pubitemid 44233455)
11. Briguori C, Airoldi F, Chieffo A, et al. Elective versus provisional intraaortic balloon pumping in unprotected left main stenting. Am Heart J. 2006 ; 152 (3). 565-572 (Pubitemid 44233423)
12. Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF.. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses. Lancet. 1999 ; 354 (9193). 1896-1900
13. Flaherty JT, Becker LC, Weiss JL, et al. Results of a randomized prospective trial of intraaortic balloon counterpulsation and intravenous nitroglycerin in patients with acute myocardial infarction. J Am Coll Cardiol. 1985 ; 6 (2). 434-446 (Pubitemid 15048823)
14. Stone GW, Marsalese D, Brodie BR, et al. A prospective, randomized evaluation of prophylactic intraaortic balloon counterpulsation in high risk patients with acute myocardial infarction treated with primary angioplasty. Second Primary Angioplasty in Myocardial Infarction (PAMI-II) Trial Investigators. J Am Coll Cardiol. 1997 ; 29 (7). 1459-1467 (Pubitemid 27272437)
15. Ohman EM, Nanas J, Stomel RJ, et al. Thrombolysis and counterpulsation to improve survival in myocardial infarction complicated by hypotension and suspected cardiogenic shock or heart failure: results of the TACTICS Trial. J Thromb Thrombolysis. 2005 ; 19 (1). 33-39 (Pubitemid 40959212)
16. Ohman EM, George BS, White CJ, et al. Use of aortic counterpulsation to improve sustained coronary artery patency during acute myocardial infarction. Results of a randomized trial. The Randomized IABP Study Group. Circulation. 1994 ; 90 (2). 792-799 (Pubitemid 24242747)
17. O'Rourke MF, Norris RM, Campbell TJ, Chang VP, Sammel NL.. Randomized controlled trial of intraaortic balloon counterpulsation in early myocardial infarction with acute heart failure. Am J Cardiol. 1981 ; 47 (4). 815-820 (Pubitemid 11150923)
18. Waksman R, Weiss AT, Gotsman MS, Hasin Y.. Intra-aortic balloon counterpulsation improves survival in cardiogenic shock complicating acute myocardial infarction. Eur Heart J. 1993 ; 14 (1). 71-74 (Pubitemid 23092642)
19. Vijayalakshmi K, Kunadian B, Whittaker VJ, et al. Intra-aortic counterpulsation does not improve coronary flow early after PCI in a high-risk group of patients: observations from a randomized trial to explore its mode of action. J Invasive Cardiol. 2007 ; 19 (8). 339-346 (Pubitemid 47290400)
20. Kono T, Morita H, Nishina T, et al. Aortic counterpulsation may improve late patency of the occluded coronary artery in patients with early failure of thrombolytic therapy. J Am Coll Cardiol. 1996 ; 28 (4). 876-881 (Pubitemid 26348151)
21. Harris RP, Helfand M, Woolf SH, et al. Current methods of the US Preventive Services Task Force: a review of the process. Am J Prev Med. 2001 ; 20 (3 suppl). 21-35 (Pubitemid 33732964)
22. Kumbasar SD, Semiz E, Sancaktar O, Yalcinkaya S, Ermis C, Deger N.. Concomitant use of intraaortic balloon counterpulsation and streptokinase in acute anterior myocardial infarction. Angiology. 1999 ; 50 (6). 465-471 (Pubitemid 29277600)
23. Brodie BR, Stuckey TD, Hansen C, Muncy D.. Intra-aortic balloon counterpulsation before primary percutaneous transluminal coronary angioplasty reduces catheterization laboratory events in high-risk patients with acute myocardial infarction. Am J Cardiol. 1999 ; 84 (1). 18-23 (Pubitemid 29307635)
24. Ohman EM, Califf RM, George BS, et al. The use of intraaortic balloon pumping as an adjunct to reperfusion therapy in acute myocardial infarction. The Thrombolysis and Angioplasty in Myocardial Infarction (TAMI) Study Group. Am Heart J. 1991 ; 121 (3 pt 1). 895-901
25. Barron HV, Every NR, Parsons LS, et al. The use of intra-aortic balloon counterpulsation in patients with cardiogenic shock complicating acute myocardial infarction: data from the National Registry of Myocardial Infarction 2. Am Heart J. 2001 ; 141 (6). 933-939
26. Kovack PJ, Rasak MA, Bates ER, Ohman EM, Stomel RJ.. Thrombolysis plus aortic counterpulsation: improved survival in patients who present to community hospitals with cardiogenic shock. J Am Coll Cardiol. 1997 ; 29 (7). 1454-1458 (Pubitemid 27274744)
27. Anderson RD, Ohman EM, Holmes DR, et al. Use of intraaortic balloon counterpulsation in patients presenting with cardiogenic shock: observations from the GUSTO-I Study. Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries. J Am Coll Cardiol. 1997 ; 30 (3). 708-715 (Pubitemid 27397651)
28. Sanborn TA, Sleeper LA, Bates ER, et al. Impact of thrombolysis, intra-aortic balloon pump counterpulsation, and their combination in cardiogenic shock complicating acute myocardial infarction: a report from the SHOCK Trial Registry. SHould we emergently revascularize Occluded Coronaries for cardiogenic shocK?. J Am Coll Cardiol. 2000 ; 36 (3 suppl A). 1123-1129
29. Stomel RJ, Rasak M, Bates ER.. Treatment strategies for acute myocardial infarction complicated by cardiogenic shock in a community hospital. Chest. 1994 ; 105 (4). 997-1002 (Pubitemid 24112779)
30. Cheng JM, Valk SD, den Uil CA, et al. Usefulness of intra-aortic balloon pump counterpulsation in patients with cardiogenic shock from acute myocardial infarction. Am J Cardiol. 2009 ; 104 (3). 327-332
31. Laish-Farkash A, Hod H, Matetzky S, Guetta V.. Safety of intra-aortic balloon pump using glycoprotein IIb/IIIa antagonists. Clin Cardiol. 2009 ; 32 (2). 99-103
32. Prondzinsky R, Lemm H, Swyter M, et al. Intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP SHOCK Trial for attenuation of multiorgan dysfunction syndrome. Crit Care Med. 2010 ; 38 (1). 152-160
33. Wang SL, Liu MX, Wang XZ, et al. Efficacy and safety of intra-aortic balloon pump-assisted interventional therapy in different age groups of patients with acute coronary syndrome. Chin Med J (Engl). 2009 ; 122 (22). 2724-2727
34. Chang SN, Hwang JJ, Chen YS, Lin JW, Chiang FT.. Clinical experience with intra-aortic balloon counterpulsation over 10 years: a retrospective cohort study of 459 patients. Resuscitation. 2008 ; 77 (3). 316-324
35. van 't Hof AW, Liem AL, de Boer MJ, Hoorntje JC, Suryapranata H, Zijlstra F.. A randomized comparison of intra-aortic balloon pumping after primary coronary angioplasty in high risk patients with acute myocardial infarction. Eur Heart J. 1999 ; 20 (9). 659-665 (Pubitemid 29204351)
36. Vis MM, Sjauw KD, van der Schaaf RJ, et al. In patients with ST-segment elevation myocardial infarction with cardiogenic shock treated with percutaneous coronary intervention, admission glucose level is a strong independent predictor for 1-year mortality in patients without a prior diagnosis of diabetes. Am Heart J. 2007 ; 154 (6). 1184-1190 (Pubitemid 350116035)
37. Vis MM, Sjauw KD, van der Schaaf RJ, et al. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol. 2007 ; 99 (9). 1201-1202 (Pubitemid 46659854)
38. Trost JC, Hillis LD.. Intra-aortic balloon counterpulsation [Review]. Am J Cardiol. 2006 ; 97 (9). 1391-1398
39. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 ; 341 (9). 625-634
40. Kern MJ, Aguirre FV, Tatineni S, Penick D, Serota H, Donohue T, Walter K.. Enhanced coronary blood flow velocity during intraaortic balloon counterpulsation in critically ill patients. J Am Coll Cardiol. 1993 ; 21 (2). 359-368 (Pubitemid 23047918)
41. Amado LC, Kraitchman DL, Gerber BL, et al. Reduction of "no-reflow" phenomenon by intra-aortic balloon counterpulsation in a randomized magnetic resonance imaging experimental study. J Am Coll Cardiol. 2004 ; 43 (7). 1291-1298 (Pubitemid 38452609)
42. Azevedo CF, Amado LC, Kraitchman DL, et al. The effect of intra-aortic balloon counterpulsation on left ventricular functional recovery early after acute myocardial infarction: a randomized experimental magnetic resonance imaging study. Eur Heart J. 2005 ; 26 (12). 1235-1241 (Pubitemid 40863131)
43. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization and long-term survival in cardiogenic shock complicating acute myocardial infarction. JAMA. 2006 ; 295 (21). 2511-2515 (Pubitemid 43854966)
44. Cheng JM, den Uil CA, Hoeks SE, et al. Percutaneous left ventricular assist devices vs. intra-aortic balloon pump counterpulsation for treatment of cardiogenic shock: a meta-analysis of controlled trials. Eur Heart J. 2009 ; 30 (17). 2102-2108
45. Stone GW, Ohman EM, Miller MF, et al. Contemporary utilization and outcomes of intra-aortic balloon counterpulsation in acute myocardial infarction: the benchmark registry. J Am Coll Cardiol. 2003 ; 41 (11). 1940-1945 (Pubitemid 36677111)
46. Bates ER, Topol EJ.. Limitations of thrombolytic therapy for acute myocardial infarction complicated by congestive heart failure and cardiogenic shock. J Am Coll Cardiol. 1991 ; 18 (4). 1077-1084
47. Prewitt RM, Gu S, Schick U, Ducas J.. Intraaortic balloon counterpulsation enhances coronary thrombolysis induced by intravenous administration of a thrombolytic agent. J Am Coll Cardiol. 1994 ; 23 (3). 794-798 (Pubitemid 24074963)
48. Hochman JS, Sleeper LA, Webb JG, et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med. 1999 ; 341 (9). 625-634